Centre médical Sheba
| Israël | Turquie | Espagne | |
| Une greffe de moelle osseuse | de $75,000 | de $36,000 | de $71,782 |
| Transplantation allogénique de moelle osseuse provenant d'un donneur non apparenté | de $135,000 | de $80,000 | de $150,000 |
| Transplantation allogénique de moelle osseuse d'un donneur apparenté | de $142,000 | de $65,000 | de $13,826 |
| Traitement complexe du sarcome d'Ewing | de $67,500 | de $30,000 | de $35,000 |
| Traitement complexe du neuroblastome | de $67,500 | de $28,000 | de $70,000 |
Bookimed ne rajoute pas de frais pour les traitements de Oncologie pédiatrique. Les tarifs proviennent des listes de prix officielles des cliniques. Vous payez directement à la clinique pour votre traitement à votre arrivée dans le pays.
Bookimed s'engage pour votre sécurité. Nous ne travaillons qu'avec des établissements médicaux qui respectent des normes internationales élevées dans le traitement de Oncologie pédiatrique et qui possèdent les licences nécessaires pour accueillir des patients internationaux dans le monde entier.
Bookimed offre une assistance experte gratuite. Un coordinateur médical personnel vous accompagne avant, pendant et après votre traitement, en résolvant tous les problèmes. Vous n'êtes jamais seul dans votre parcours de traitement de Oncologie pédiatrique.
Plus de 300 greffes pédiatriques de moelle osseuse et de sang de cordon effectuées – Le Dr El Hasid dirige le département d'onco-hématologie pédiatrique de l'hôpital pour enfants Dana Dwek.
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.
She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.
She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.
She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.
Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.
He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.
Primary pediatric treatments in Israel center on advanced oncology and hematology protocols. Highly specialized children's hospitals provide leukemia chemotherapy, bone marrow transplants, and robotic surgery for solid tumors. These facilities utilize Joint Commission International (JCI) standards to ensure high-quality, clinical care for complex cases.
Bookimed Expert Insight: Israeli pediatric centers show a unique pattern of surgical collaboration. At Sourasky, neurosurgeons and orthopedic specialists co-manage bone cancers. This integrated approach allows for more complete tumor removal in complex cases. Such cooperation is common in hospitals serving 11,000+ children annually.
Patient Consensus: Parents note that treatment protocols match top international standards. They appreciate that major centers provide multilingual staff and housing to support families during long-term stays.
Israeli pediatric oncology distinguishes itself through family-centric infrastructure and specialized long-term monitoring. Doctors prioritize outpatient ambulatory care to maintain normal childhood development. Dedicated centers like the Schneider Center for Children Medicine and Hadassah Medical Center employ higher safety standards, including positive pressure entranceways, to protect immunocompromised children.
Bookimed Expert Insight: Israeli pediatric centers show a unique pattern where primary oncologists, like Dr. Gal Goldstein at Hadassah, manage the entire patient journey. This contrasts with adult care, where patients often move between multiple specialists. This continuity ensures that complex histories involving rare blood cancers or retinoblastoma are never lost during transitions, a common challenge in high-volume adult wards.
Patient Consensus: Parents find that pediatric units treat them as equal care partners and involve children in age-appropriate medical discussions. Many note it is helpful that hospitals coordinate with schools to keep children from falling behind in their education during intensive treatments.
Children in Israel have direct access to international clinical trials through major research hospitals. Facilities like Sourasky Medical Center and Hadassah Medical Center participate in global networks. These include the Children's Oncology Group (COG). They also work with the International Society of Pediatric Oncology (SIOP).
Bookimed Expert Insight: Israeli pediatric centers often lead in trial availability due to high patient volumes. Hadassah and Sheba each serve over 1,000,000 patients annually. This scale attracts international sponsors for rare disease studies. Patients at these centers often access targeted therapies earlier than in smaller regional hospitals. Always check if a trial is active at your specific diagnosis date.
Patient Consensus: Parents note that trial participation is highly selective and based on strict timing. They recommend asking for an explicit list of active trials immediately at diagnosis. Many found that navigating consent forms may require translation support as some documentation is in Hebrew.
International families in Israel access non-medical support through hospital social departments, non-governmental organizations (NGOs), and specialized international patient centers. These services include subsidized housing, linguistic mediation, and bureaucratic guidance. Facilities like Hadassah Medical Center and Sourasky Medical Center provide dedicated coordinators to assist with logistics and integration.
Bookimed Expert Insight: Data from high-volume centers like Hadassah Medical Center, serving 1,000,000 patients annually, shows a sophisticated support infrastructure. Families often overlook that private clinics like Assuta Medical Center allow patients to choose specific physicians. This flexibility extends to recovery environments, which can significantly lower the stress of long-term pediatric oncology stays.
Patient Consensus: Parents emphasize that a local support person is essential for navigating insurance and bureaucratic delays. Finding hospital-affiliated lodging early is a top priority, as rental costs are a major financial drain.
Parents in Israel are encouraged to stay with their child 24/7 during pediatric oncology treatment. Hospitals like Sourasky Medical Center and Hadassah Medical Center provide in-room accommodations. This family-centered approach supports recovery during intensive procedures like chemotherapy or bone marrow transplantation.
Bookimed Expert Insight: Israeli pediatric centers prioritize parental presence as a clinical necessity rather than a luxury. Facilities like the Schneider Center for Children Medicine, which serves 275,000 patients annually, integrate family spaces directly into ward designs. Our data shows that clinics with high international volumes often coordinate these logistics through dedicated social workers to ensure seamless transitions for traveling families.
Patient Consensus: Patients note that staying overnight is socially expected in Israel, with nurses providing comfy chair-beds for parents. One parent mentioned it is helpful to pack for a 24/7 stay as facilities like laundry and showers are usually located right next to the ward.
English is widely spoken by medical specialists in Israeli pediatric oncology departments. Most physicians hold international certifications or have trained in the United States and Europe. While doctors are fluent, English proficiency among nursing and administrative staff varies by facility and location.
Bookimed Expert Insight: Our data shows a clear trend in Tel Aviv clinics like Sourasky (Ichilov). These centers treat over 400,000 patients annually and have dedicated international departments. This high volume of foreign cases means that pediatric oncology units are better equipped with English-speaking coordinators than smaller regional hospitals like those in Haifa.
Patient Consensus: Parents note that while oncologists communicate complex details clearly in English, daily interactions with receptionists can be difficult. Many suggest requesting an English-speaking liaison during the first appointment to handle administrative tasks and discharge paperwork.
Les services hospitaliers israéliens restent opérationnels pendant le sabbat. La loi juive privilégie le sauvetage des vies à travers le principe de Pikuach Nefesh. Celui-ci prévaut sur les interdits religieux pour les soins médicaux. Les services d'oncologie pédiatrique dans des centres comme le Hadassah Medical Center continuent à fournir une chimiothérapie essentielle et un suivi 24/7.
Aperçu d'expert Bookimed : Les centres médicaux israéliens programment souvent des procédures complexes comme les greffes de moelle osseuse du dimanche au jeudi. Nos données montrent que cela garantit un soutien administratif et de laboratoire complet durant les 48 heures critiques. Des centres comme le Sourasky Medical Center priorisent ce calendrier afin de maintenir leur taux de succès oncologique de 90 %.
Consensus des patients : Les patients notent que bien que les soins médicaux restent constants, le transport devient difficile car les bus publics s'arrêtent. Ils suggèrent de réserver des taxis privés ou de rester près de l'hôpital du vendredi après-midi au samedi soir.